Filing Details

Accession Number:
0001127602-10-001940
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-21 12:00:00
Reporting Period:
2010-01-19
Filing Date:
2010-01-21
Accepted Time:
2010-01-21 15:28:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
794172 Meridian Bioscience Inc VIVO In Vitro & In Vivo Diagnostic Substances (2835) 310888197
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1224662 A John Kraeutler 3471 River Hills Drive
Cincinnati OH 45244
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-19 24,400 $22.17 250,860 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. As a result of technological limitations of the EDGAR system, this Form 4 is being filed in two parts: this current reportand another Form 4 of the reporting party filed on the same date. To minimize confusion, only the current report includesthe information in Table II. As such, both this Form and the other Form 4 of the reporting party filed on the same dateshould be read in tandem.
  2. As a result of technological limitations of the EDGAR system, this Form 4 is being filed in two parts: this current reportand another Form 4 of the reporting party filed on the same date. To minimize confusion, only the other report of thereporting party filed on the same date includes the information in Table II. As such, both this Form and the other Form 4 ofthe reporting party filed on the same date should be read in tandem.
  3. Prices ranged from $22.00 to $22.28 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a securityholder of the issuer.
  4. Sales made pursuant to a Rule 10b5-1 trading plan.